Immuron Limited (IMRN) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
IMRN Revenue Growth
Revenue Breakdown (FY 2021)
IMRN's revenue distribution by segment and geography for fiscal year 2021
By Product/Segment
IMRN Revenue Analysis (2014–2025)
As of May 8, 2026, Immuron Limited (IMRN) generated trailing twelve-month (TTM) revenue of $10.9 million, reflecting exceptional growth of +29.3% year-over-year. The most recent quarter (Q4 2025) recorded $3.3 million in revenue, up 100.0% sequentially.
Looking at the longer-term picture, IMRN's 5-year compound annual growth rate (CAGR) stands at +23.7%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $7.3 million in 2025, representing a new all-time high.
Revenue diversification analysis shows IMRN's business is primarily driven by ProtectynMember (100%). With over half of revenue concentrated in ProtectynMember, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including HALO (+37.6% YoY), ADMA (+11.0% YoY), and AGEN (+10.4% YoY), IMRN has underperformed the peer group in terms of revenue growth. Compare IMRN vs HALO →
IMRN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| IMRNCurrent | $11M | +29.3% | +23.7% | -73.3% | |
 HALO | $1.4B | +37.6% | +39.2% | 58.4% | |
 ADMA | $510M | +11.0% | +64.6% | 37.5% | |
 AGEN | $114M | +10.4% | +5.3% | -18.0% | |
 NVAX | $1.1B | -52.5% | +118.8% | 50.1% | |
 VXRT | $237M | +726.7% | +125.8% | 7.6% |
IMRN Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $7.3M | +48.6% | $4.8M | 65.4% | $-5,344,548 | -73.3% |
| 2024 | $4.9M | +171.7% | $3.3M | 68.1% | $-5,801,118 | -118.3% |
| 2023 | $1.8M | +135.8% | $1.7M | 96.4% | $-3,568,838 | -197.8% |
| 2022 | $765K | +424.9% | $524K | 68.4% | $-2,869,855 | -375.0% |
| 2021 | $146K | -94.2% | $-665,060 | -456.2% | $-8,379,908 | -5748.5% |
| 2020 | $2.5M | +5.5% | $1.8M | 72.6% | $-2,905,575 | -115.4% |
| 2019 | $2.4M | +29.5% | $1.7M | 71.5% | $-4,656,460 | -195.0% |
| 2018 | $1.8M | +32.0% | $1.3M | 68.4% | $-2,987,968 | -162.1% |
| 2017 | $1.4M | +39.5% | $922K | 66.0% | $-8,389,122 | -600.9% |
| 2016 | $1.0M | -0.1% | $695K | 69.5% | $-8,262,290 | -825.3% |
See IMRN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IMRN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IMRN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIMRN — Frequently Asked Questions
Quick answers to the most common questions about buying IMRN stock.
Is IMRN's revenue growth accelerating or slowing?
IMRN revenue is accelerating at +29.3% year-over-year, exceeding the 5-year CAGR of +23.7%. TTM revenue reached $11M. Growth momentum has increased versus prior periods.
What is IMRN's long-term revenue growth rate?
Immuron Limited's 5-year revenue CAGR of +23.7% reflects the sustained expansion pattern. Current YoY growth of +29.3% is above this long-term average.
How is IMRN's revenue distributed by segment?
IMRN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.